Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCG-IV is an effective agonist of class II mGluR. DCG-IV has anticonvulsant and neuroprotective effects. The EC50 of mGlu2R and mGlu3R are 0.35 and 0.09 μM, respectively. DCG-IV is also a competitive antagonist of Group I (IC50: mGlu1 / 5R = 389/630 μM) and III receptor (IC50: mGlu4 / 6/7 / 8R = 22.5 / 39.6 / 40.1 / 32 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 4-5 weeks | $ 745.00 | |
10 mg | 4-5 weeks | $ 1,590.00 | |
50 mg | 4-5 weeks | $ 6,410.00 |
Description | DCG-IV is an effective agonist of class II mGluR. DCG-IV has anticonvulsant and neuroprotective effects. The EC50 of mGlu2R and mGlu3R are 0.35 and 0.09 μM, respectively. DCG-IV is also a competitive antagonist of Group I (IC50: mGlu1 / 5R = 389/630 μM) and III receptor (IC50: mGlu4 / 6/7 / 8R = 22.5 / 39.6 / 40.1 / 32 μM). |
Targets&IC50 | mGluR5:630 μM (IC50), mGluR1R:389 μM (IC50), mGluR2R:0.35 μM (EC50), mGluR6:39.6 μM (IC50), mGluR3R:0.09 μM (EC50), mGluR4R:22.5 μM (IC50), mGluR7:40.1 μM (IC50), mGluR8:32 μM (IC50) |
In vitro | DCG-IV is also a NMDA receptor agonist in rat cerebral cortex. |
In vivo | DCG-IV (1-10 mg / kg; i.p.) inhibits hyperactivity caused by phencyclidine (PCP). |
Molecular Weight | 203.15 |
Formula | C7H9NO6 |
CAS No. | 147782-19-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DCG-IV 147782-19-2 Others DCG IV DCGIV inhibitor inhibit